Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2019; 15
DOI: 10.1055/s-0044-1797824
E-PÔSTER
TEMÁRIO: ONCOMASTOLOGIA

EPIDEMIOLOGICAL PROFILE OF BREAST NEOPLASMS IN BRAZILIAN FEMALE POPULATION FOR THE PERIOD OF 2008-2018

Caenna Corrêa e Correia
1   FMB/UFBA - LANACC/FMB
,
Beatriz Gedeon Cubilhas
2   EBMSP - LANACC/FMB
,
Gildásio Do Nascimento Santos Jr.
1   FMB/UFBA - LANACC/FMB
,
Hortênsia Souza Guedes de Oliveira
2   EBMSP - LANACC/FMB
,
Ian Lemos Teixeira Sarno
2   EBMSP - LANACC/FMB
,
Milla Gabriele Sallenave Andrade
2   EBMSP - LANACC/FMB
,
Pedro de Brito Oliveira
2   EBMSP - LANACC/FMB
,
Renata Cristina Perez de Magalhães
2   EBMSP - LANACC/FMB
,
Ana Célia Diniz Cabral Barbosa Romeo
3   FMB/UFBA
,
André Luis Barbosa Romeo
4   EBMSP
› Author Affiliations
 

    Introduction: Breast cancer is the one that most affects women worldwide, with 1.38 million new cases and 458 thousand deaths per year, according to WHO. There are several types of this neoplasm, and most cases have a good prognosis. For the year 2018, 59,700 new cases of breast cancer were estimated in Brazil. Objective: To delineate the epidemiological profile of patients hospitalized in Brazil with malignant breast cancer, focusing on females, between 2008 and 2018. Method: Through the Sistema de Informações Hospitalares (SIH / DATASUS) database, hospitalizations were analyzed and deaths related to malignant breast cancer in Brazil, from 2008 to 2018, especially in women. Refers to an ecological study with a quantitative, descriptive and temporal approach, in which the variables studied were: number of hospitalizations and deaths according to year, region, race, and age in addition to the value total and average according to regions. Results: Hospitalizations for malignant breast cancer increased over time, with 37,744 in 2008 and 63,542 in 2018. These were more frequent among self-reported white women, totaling 263,098, and less frequent among indigenous women, who make up only 237. Mortality was the other way around, with 13.08 among indigenous women and 8.07 among white women. Among age groups, mortality was highest between 1-4 years, at 16.67, followed by 80 years and over, at 15.76. The age group with the largest number of hospitalizations was between 5059 years old, representing 158,348 cases. Women from the Southeast region had the highest number of hospitalizations, with 290,894, in the referred time interval. However, it was the Northeast region that presented the highest average value of hospitalizations, being R $ 2,062.28. Conclusion: There is an increase in hospitalizations for malignant breast cancer during the study period, which may be justified by the increased worldwide incidence of this cancer. There was a higher number of hospitalizations and lower mortality among self-declared white women, and the opposite among indigenous women, which can be attributed to difficulties in accessing health in socially vulnerable groups. Finally, the highest hospitalization rate of 50-59 years may be related to the use of mammography for screening, which begins after 50 years.


    No conflict of interest has been declared by the author(s).

    Contato:

    Caenna Corrêa e Correia

    Publication History

    Article published online:
    23 October 2019

    © 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

    Bibliographical Record
    Caenna Corrêa e Correia, Beatriz Gedeon Cubilhas, Gildásio Do Nascimento Santos, Hortênsia Souza Guedes de Oliveira, Ian Lemos Teixeira Sarno, Milla Gabriele Sallenave Andrade, Pedro de Brito Oliveira, Renata Cristina Perez de Magalhães, Ana Célia Diniz Cabral Barbosa Romeo, André Luis Barbosa Romeo. EPIDEMIOLOGICAL PROFILE OF BREAST NEOPLASMS IN BRAZILIAN FEMALE POPULATION FOR THE PERIOD OF 2008-2018. Brazilian Journal of Oncology 2019; 15.
    DOI: 10.1055/s-0044-1797824